The observed effects of Trim31 on Rhbdf2 signaling-associated hepatic steatosis, inflammation, and insulin resistance prompted us to examine whether Trim31 directly interacts with Rhbdf2 during the development of NAFLD. Here, TRIM31 is linked to fatty liver disease.